Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04506866 · ClinicalTrials.gov registry record · NA
InterStim Micro Post Market Clinical Follow-up Study (ELITE)
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT04506866 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 148 participants.
The verdict
NCT04506866, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the InterStim Micro System for sacral neuromodulation.
Interventions
- DEVICE InterStim Micro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2023-12-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04506866
The ClinicalTrials.gov registry entry for NCT04506866 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which InterStim Micro is the first listed.
NCT04506866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04506866 about?
NCT04506866 is a clinical study titled "InterStim Micro Post Market Clinical Follow-up Study (ELITE)". Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the InterStim Micro System for sacral neuromodulation.
What is the current status of trial NCT04506866?
This trial is currently terminated. It is a NA study. The enrollment target is 148 participants. The study started on 2020-08-25. Estimated completion is 2023-12-08.
What interventions are being tested in trial NCT04506866?
The interventions under investigation include: InterStim Micro (DEVICE).
Who is sponsoring clinical trial NCT04506866?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.